皮肤T细胞淋巴瘤的新型药物

Novel agents for cutaneous T-cell lymphoma.

作者信息

Kuzel Timothy M, Junghans Richard, Foss Francine M

机构信息

Division of Hematology/Oncology, The Feinberg School of Medicine, and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 675 North St. Clair, Suite 21-100, Chicago, IL 60611, USA.

出版信息

Hematol Oncol Clin North Am. 2003 Dec;17(6):1459-66, x. doi: 10.1016/s0889-8588(03)00112-6.

DOI:10.1016/s0889-8588(03)00112-6

PMID:14710896

Abstract

Several novel therapies have recently emerged for the treatment of hematologic malignancies; several agents have demonstrated activity against T-cell lymphomas in vitro or in early clinical trials. This article discusses how these therapies may be implemented in the treatment of patients who have advanced or refractory cutaneous T-cell lymphoma.

摘要

最近出现了几种用于治疗血液系统恶性肿瘤的新型疗法；几种药物已在体外或早期临床试验中显示出对T细胞淋巴瘤的活性。本文讨论了这些疗法如何应用于晚期或难治性皮肤T细胞淋巴瘤患者的治疗。